Document Classification

Section Type: RESULTS

Text: Pegvisomant decreased IGF-I in CONS and NORMS [158. 5 (101-206) vs. 103 (77-125) microg/l, P < 0. 01 ; 124 (81-136) vs. 95 (51-113) microg/l, P < 0. 01 respectively], but not in LOWS [31 (< 31-32) vs. 34. 5 (< 31-38) microg/l], and this was associated with an increase in mean 24 h GH in CONS [0. 49 (0. 12-0. 89) to 1. 38 (0. 22-2. 45) microg/l (P = 0. 03)] and in NORMS [69 (0-320) % from 0. 1 (< 0. 1-0. 13) to 0. 17 (0. 11-0. 42) microg/l (P = 0. 03)], but not in the LOWS.